Nobel Prize Winner Jumper Leaves DeepMind for Anthropic

John Jumper, a Nobel Prize in Chemistry winner at DeepMind, Google's AI research subsidiary, has announced his departure from the organization to join Anthropic, a competing AI company. Jumper is a researcher who played a central role in developing AlphaFold, an AI system that predicts the three-dimensional structure of proteins, and his contributions led to receiving the Nobel Prize in 2024.

This move is not limited to Jumper alone. According to reports, other notable researchers have also been leaving DeepMind in succession, and the organization is experiencing continued talent attrition. As the AI industry intensifies competition for acquiring excellent research talent, such moves are becoming increasingly common. However, the departure of a Nobel Prize laureate, an extremely symbolic figure, is considered an unprecedented event in the industry.

Anthropic, the destination of his move, is an AI safety research-focused company founded in 2021 by former executives of OpenAI. It develops and provides the large language model Claude series and has increased its presence as a major AI development player alongside OpenAI and Google. Details regarding what role Jumper will assume at Anthropic have not yet been disclosed.

DeepMind has built a strong reputation in the academic and research community through numerous scientific achievements, including AlphaFold. However, there are also views that in recent years, friction has emerged between Google's policy of accelerating the societal implementation of research outcomes and researchers' preference for fundamental research. It cannot be ruled out that this series of talent departures reflects such organizational tensions.

At the forefront of AI research, a structure has become established in which major tech companies and emerging AI startups compete for the same talent pool. For researchers, choices that prioritize research freedom and organizational direction over abundant resources of large organizations are becoming realistic options. Jumper's move can be seen as an example of career choices based on such individual values.

The focus going forward lies on how DeepMind will stem the outflow of talent and how Anthropic will leverage Jumper's expertise in its own research and development. In particular, the convergence of AI technology and life sciences fields such as protein structure prediction is a promising area with expanding applications in drug discovery and healthcare, and how Anthropic utilizes this knowledge is worth noting.